DIAGNOS Inc. (CVE:ADK – Get Free Report) shares were down 1.5% during trading on Tuesday . The stock traded as low as C$0.33 and last traded at C$0.34. Approximately 103,500 shares were traded during mid-day trading, an increase of 14% from the average daily volume of 90,800 shares. The stock had previously closed at C$0.34.
Analyst Upgrades and Downgrades
Separately, Ventum Cap Mkts upgraded DIAGNOS to a “strong-buy” rating in a report on Wednesday, July 17th.
Get Our Latest Analysis on ADK
DIAGNOS Stock Performance
DIAGNOS (CVE:ADK – Get Free Report) last released its quarterly earnings data on Wednesday, August 21st. The company reported C($0.01) EPS for the quarter, topping the consensus estimate of C($0.02) by C$0.01. The company had revenue of C$0.04 million during the quarter, compared to analysts’ expectations of C$0.07 million. Analysts expect that DIAGNOS Inc. will post -0.02 earnings per share for the current year.
DIAGNOS Company Profile
DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes.
Featured Articles
- Five stocks we like better than DIAGNOS
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Is McDonald’s Stock a Smart Buy After Sell-Off and Earnings?
- Stock Average Calculator
- QuantumScape: Solid State EV Batteries Nearing Commercialization
- Dividend Payout Ratio Calculator
- MicroStrategy: Is This Bitcoin-Powered Stock a Buy or a Gamble?
Receive News & Ratings for DIAGNOS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DIAGNOS and related companies with MarketBeat.com's FREE daily email newsletter.